Última Hora: "Draghi vê inflação a crescer na Zona Euro e leva juros da dívida e euro a subir - Jornal de Negócios - Portugal" Mon, 24 Sep 2018 14:23:15 GMT    "PCP avança com resolução para fixar salário mínimo em 650 euros - Observador" Mon, 24 Sep 2018 15:23:07 GMT    "Portugal apresenta os salários mais altos em sectores altamente qualificados como as TI - SAPO Tek" Mon, 24 Sep 2018 13:03:27 GMT    "Manuel Pinho suspeito de recorrer a perdão fiscal para legalizar pagamentos do BES - Observador" Mon, 24 Sep 2018 08:05:11 GMT    "As massas mobilizam-se para a liderança climática - Jornal de Negócios - Portugal" Sun, 23 Sep 2018 16:54:00 GMT    "Mário Lino ilibado no negócio ruinoso da TAP no Brasil - Jornal de Negócios - Portugal" Mon, 24 Sep 2018 08:04:00 GMT   "" Mon, 24 Sep 2018 16:47:00 GMT    "Altice aponta ilegalidades e "erros de facto e de direito" na multa milionária de Bruxelas - Jornal de Negócios - Portugal" Mon, 24 Sep 2018 10:30:05 GMT    "Porsche anuncia adeus aos motores diesel em definitivo - Record" Mon, 24 Sep 2018 15:47:59 GMT    "Novo regime dos recibos verdes vai abranger 300 mil trabalhadores - ECO Economia Online" Mon, 24 Sep 2018 15:32:35 GMT      Para mais notícias, clique aqui.

Área de Acesso
       
       
Lembrar Sempre 
(Login BolsaPT & Canal Forex)

Procure análises técnicas no nosso fórum aqui: Análises Técnicas
Nota: Os dados após 2009-10-29 são ainda temporários e poderão por isso ter o valor de Abertura errado até nova actualização...
Mudar para Gráfico Estático de Sepracor Inc.

Sem variação
Sepracor Inc. - [Ticker: SEPR]Gráfico Sepracor Inc.  Notícias Sepracor Inc.  Download de Históricos Metastock Sepracor Inc. e Outros  Análise Técnica Sepracor Inc.  
Última Trade0,000Range 52 Semanas[0,000 - 0,000]
Hora da Última Trade - 00:00:00Price-Target 1 Ano0,000
VariaçãoN/A (N/A)Capitalização Bolsista0
Bid / AskN/AEPS0,00
Abertura0,000PER0,00%
Máximo0,000Pagamento Dividendo
Mínimo0,000Data Ex-Dividendo
Fecho Anterior0,000Yield
Volume0Volume Médio (3m)0
Nota: Os dados podem apresentar atraso de alguns minutos.

 Notícias sobre Sepracor Inc. [SEPR]:   (ordenadas por relevância)

Paris Ledger

Global Asthma Medication Market Analysis 2018-2025 : Dulera, Merck, Roche, Sepracor, Sanofi
Paris Ledger
The competitive analysis contains identifying the key common trends and major players in the market such as [Dulera, QVAR, Glaxosmithkline plc, MAP Pharmaceuticals,Inc, Merck & Co. Inc, AstraZeneca plc, Roche Holdings Ltd, Genentech Inc, Sepracor, Inc, ...

e mais »

Medgadget (blog)

Obstructive Lung Disease Market 2018 Epidemiology, Drugs Uptake, Upcoming Therapies and Highly Analysed ...
Medgadget (blog)
(U.S.), Genentech Inc. (U.S.), Sepracor, Inc. (U.S.), Skyepharma plc (U.S.). Global Obstructive Lung Disease Market: Segmentation. The obstructive lung disease is segmented on the basis of disease type, product type, drug class, route of administration ...

e mais »

Photocure ASA: Daniel Schneider appointed Chief Executive Officer
GlobeNewswire (press release)
Mr Schneider has also held executive management positions in other pharmaceutical and biotech companies, including BTG International, Somaxon Pharmaceuticals and Sepracor. ... The US headquarters for Photocure Inc., are in Princeton, New Jersey.

e mais »

Three PM News (blog)

Global Desloratadine Market 2018 Major Players ? Hairui Pharmaceutical, Mayne Pharma Inc, Pfizer, Sepracor, Mylan ...
Three PM News (blog)
Global Desloratadine Market Research Report 2018-2023 published and promoted by GenMarketInsights.com provides in-depth segment analysis of the market being effective in several sectors, thereby providing valuable insights to the rivals.


The Business Investor

Global Asthma Medication Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 ? 2025
The Business Investor
Global Asthma Medication market is valued at USD XX million in 2018 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2018 and 2022. Asthma is chronic inflammatory lung disease. Asthma affects the ...


Tactical Business

Asthma Medication-Global Market Outlook 2018-2025
Tactical Business
Global Asthma Medication Market : This report studies the global market size of Asthma Medication in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Asthma Medication ...

e mais »

managementjournal24.com

Asthma Medication Market to 2025 ?Global Market Size, Development Status, Top Manufacturers, and Forecasts
managementjournal24.com
Global Asthma Medication market Review Forecast to 2023 ? Analysis by Chemical Type, Technology, Application, End-User, Industry Vertical, and Region' into its vast depository of research reports. In the first section of the report, the market ...

e mais »

Desloratadine Market Analysis, Overview, Growth, Demand and Forecast Research Report to 2025
Chronicle India
Top Key Players of Desloratadine Market: Pfizer, Teva, Wante Pharmaceutical, Novartis India Limited, Mylan, Sepracor, Sandoz, Apollo Pharmaceuticals, GSK, Mayne Pharma Inc, Abhilasha Pharma Pvt, Abbott, Takeda, Schering-Plough, Nanjing Hicin ...


CB Reporter

Worldwide Desloratadine Market Research Report 2018: Progress, Size, Share, Development, Trends And Estimates ...
CB Reporter
Desloratadine Market Segment by Manufacturers includes: Pfizer, Teva, Wante Pharmaceutical, Novartis India Limited, Mylan, Sepracor, Sandoz, Apollo Pharmaceuticals, GSK, Mayne Pharma Inc, Abhilasha Pharma Pvt, Abbott, Takeda, Schering-Plough, ...

e mais »

Global Desloratadine Market Growth Trends,Type ,Application , Revenue ,Size ,Demand , Research Approach and ...
Trade Market Research
Pfizer, Teva, Wante Pharmaceutical, Novartis India Limited, Mylan, Sepracor, Sandoz, Apollo Pharmaceuticals, GSK, Mayne Pharma Inc, Abhilasha Pharma Pvt, Abbott, Takeda, Schering-Plough, Nanjing Hicin Pharmaceutical, Hairui Pharmaceutical, Hainan ...

e mais »

trueindustrynews.com

Global Asthma and COPD Drugs market is expected to reach $50359 million by 2022
trueindustrynews.com
... (U.K), Roche Holding AG (Switzerland), Teva Pharmaceutical Industries (Israel), Vectura Group (U.K), Pfizer (U.S). Other players in the value chain include Mylan, Aerovance Inc. Alkermes Inc. Almirall SA. Genentech Inc. Sepracor, Inc. Skyepharma plc.

e mais »

Asthma Medication Market Insights, Forecast to 2025 Market By Manufactures, Product scope and Trends 2018 to 2023
theperfectinvestor.com
Global Asthma Medication Market Insights, Forecast to 2025 Market Professional Survey Report 2018?provides strategists, marketers and senior management with the critical information they need to assess the global Asthma Medication Market Insights, ...

e mais »

BSA bureau (press release)

Sumitomo Dainippon appoints Nomura as President & CEO
BSA bureau (press release)
In 2010, Sunovion (formerly Sepracor Inc.), was acquired by Sumitomo Dainippon. Nomura took the position of the Vice Chair, Executive Vice President and CFO, Sunovion Pharmaceuticals Inc. in 2012. Following 2014, he became associated with the ...

e mais »

GlobeNewswire (press release)

Arbutus Strengthens Management Team With Appointment of David C. Hastings as New Chief Financial Officer
GlobeNewswire (press release)
Mr. Hastings also previously served as Vice President, Chief Financial Officer and Treasurer of ArQule Inc. During his tenure at ArQule, he played an important role in ArQule's transition into a drug discovery and development organization, and in two ...


Business Wire (press release)

Kala Pharmaceuticals Appoints Eric Trachtenberg as General Counsel and Corporate Secretary
Business Wire (press release)
Prior to Auxilium, he was Vice President, General Counsel and Corporate Secretary of Enobia Pharma, Inc. Prior to that, Mr. Trachtenberg served as Vice President and Associate General Counsel of Sepracor Inc. (now known as Sunovion Pharmaceuticals ...

e mais »
Para mais notícias sobre Sepracor Inc. clique aqui:
Notícias de Sepracor Inc. 


Largura do Site:

 Imagem de Fundo:

Copyright@1998-2018 - BolsaPT.com, todos os direitos reservados.
Fórum de Bolsa Cotações de Bolsa Notícias de Bolsa Chat de Bolsa Disclaimer Recursos para Webmasters